PTGX Market Cap History
Below is a table of the PTGX market cap history going back to 8/31/2016:

Date PTGX Market Cap
8/31/2016197.70M
10/31/2016314.23M
2/28/2017232.68M
4/28/2017170.59M
7/31/2017206.04M
10/31/2017306.58M
2/28/2018357.71M
4/30/2018183.20M
7/31/2018146.83M
10/31/2018193.25M
2/28/2019187.24M
4/30/2019241.68M
7/31/2019289.61M
3/7/2019137.22M
10/31/2019365.93M
2/28/2020212.90M
4/30/2020185.18M
7/31/2020578.98M
10/30/2020724.97M

Also see: PTGX Shares Outstanding History
and PTGX YTD Return
PTGX Historical Market Cap:
+36.59% CAGR
PTGX Historical Market Cap: +36.59% CAGR

Mouse over chart for data details
8/31/2016 ...10/30/2020
Protagonist Therapeutics is a clinical-stage biopharmaceutical company that utilizes a proprietary technology platform to discover and develop peptide-based drugs. Co.'s clinical asset, PTG-300, is an injectable hepcidin mimetic in development for the potential treatment of iron overload and other blood disorders. Co. is developing PTG-300 for the treatment of ineffective erythropoiesis, chronic anemia and iron overload, with an initial focus on beta-thalassemia non-transfusion dependent and transfusion dependent patients. Co.'s other clinical assets, PTG-200 and PN-943, are orally delivered drugs in development for inflammatory bowel disease. We show 19 historical shares outstanding datapoints in our PTGX shares outstanding history coverage, used to compute PTGX market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing PTGX market cap history over the course of time is important for investors interested in comparing PTGX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of PTGX versus a peer is one thing; comparing PTGX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like PTGX can fluctuate over the course of history. With this page we aim to empower investors researching PTGX by allowing them to research the PTGX market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for PTGX:
PTGX SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Protagonist Therapeutics (PTGX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

PTI Market Cap History
PTIE Market Cap History
PTLA Market Cap History
PTX Market Cap History
PULM Market Cap History
QDEL Market Cap History
QGEN Market Cap History
QHC Market Cap History
RARE Market Cap History
RARX Market Cap History
More Healthcare companies »

 

PTGX Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2020, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.